⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278339 | 0.82 | KDM4E (0.38) | — | |
| SCHEMBL20504550 | 0.82 | KDM4E (0.38) | — | |
| SCHEMBL383606 | 0.81 | HDAC8 (0.36) | — | |
| SCHEMBL27905560 | 0.78 | CCR2 (0.40) | — | |
| Ammonia Solution, Strong SCHEMBL26087349 | 0.76 | MMP1 (0.33) | — | |
| SCHEMBL27823589 | 0.76 | EGLN1 (0.32) | — | |
| SCHEMBL3279366 | 0.76 | KDM4E (0.32) | — | |
| SCHEMBL8973990 | 0.75 | — | — | |
| SCHEMBL10338006 | 0.75 | MMP1 (0.39) | — | |
| SCHEMBL10349293 | 0.75 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250302973-A1 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | MGGM LLC | 2025-10-02 | — | — | US | claimed |
| EP-4522135-A2 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | University of Padova (IT) | 2025-03-19 | — | — | EP | claimed |
| US-20240245789-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGETS RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2024-07-25 | — | — | US | claimed |
| EP-4337194-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGET RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2024-03-20 | — | — | EP | claimed |
| CN-117693338-A | Polymer conjugates of drugs targeting 5-HT and other receptors in the Central Nervous System (CNS) and also targeting receptors outside the CNS | 阿伯门蒂斯有限责任公司 | 2024-03-12 | — | — | CN | claimed |
| WO-2023220379-A2 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | UNIVERSITY OF PADOVA (IT) | 2023-11-16 | — | — | WO | claimed |
| WO-2022240853-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGET RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2022-11-17 | — | — | WO | claimed |
| EP-2968584-A1 | VACCINATION COMPOSITION | Cristal Delivery B.V. (NL) | 2016-01-20 | — | — | EP | claimed |
| WO-2014142653-A1 | VACCINATION COMPOSITION | CRISTAL DELIVERY B.V. (NL) | 2014-09-18 | — | — | WO | claimed |
| EP-2349345-A1 | METHOD FOR THE PREPARATION OF A CONTROLLED RELEASE SYSTEM | Universiteit Utrecht Holding B.V. (NL) | 2011-08-03 | — | — | EP | claimed |
| WO-2010033022-A1 | METHOD FOR THE PREPARATION OF A CONTROLLED RELEASE SYSTEM | UNIVERSITEIT UTRECHT HOLDING B.V. (NL) | 2010-03-25 | — | — | WO | claimed |
| US-20250302973-A1 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | MGGM LLC | 2025-10-02 | — | — | US | disclosed |
| EP-4522135-A2 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | University of Padova (IT) | 2025-03-19 | — | — | EP | disclosed |
| US-20240245789-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGETS RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2024-07-25 | — | — | US | disclosed |
| EP-4337194-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGET RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2024-03-20 | — | — | EP | disclosed |
| CN-117693338-A | Polymer conjugates of drugs targeting 5-HT and other receptors in the Central Nervous System (CNS) and also targeting receptors outside the CNS | 阿伯门蒂斯有限责任公司 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023220379-A2 | POLYMER CONJUGATES OF DRUGS WITH CENTRAL NERVOUS SYSTEM (CNS) EFFECTS AND PERIPHERAL NMDAR BLOCKING ACTIVITY AND/OR IMMUNE SYSTEM MODULATING EFFECTS | UNIVERSITY OF PADOVA (IT) | 2023-11-16 | — | — | WO | disclosed |
| WO-2022240853-A1 | POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGET RECEPTORS OUTSIDE OF THE CNS | Arbormentis LLC (US) | 2022-11-17 | — | — | WO | disclosed |